1985
DOI: 10.1007/bf00265041
|View full text |Cite
|
Sign up to set email alerts
|

In vivo determination of the kinetic parameters of glucose transport in the human brain using 11C-methyl-d-glucose (CMG) and dynamic positron emission tomography (dPET)

Abstract: A method was developed to measure simultaneously the rate constants for glucose influx and glucose efflux, and the Michaelis-Menten constant (KM) and maximal velocity (Vmax) for glucose transport across the blood-brain barrier (BBB) in any selected brain area. Moreover, on the basis of a mathematical model, the local perfusion rate (LPR) and local unidirectional glucose transport rate (LUGTR) are calculated in terms of parameters of the time-activity curves registered over different brain regions; 11C-methyl-D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1988
1988
2011
2011

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…The primary effects of glucose trans port on the calculation of V tca are described by the parameter llt1h' Glucose transport kinetic constants of 4.9 mM for Km and 3.6 for V m a x/CMRgl deter mined by l3C NMR (Gruetter et aI., 1992a) with a TCA cycle rate V tca = 0.729 /-lmol min -1 g -1 led to a value of 1.50 min for lltl/2 during a typical [1-l3C]glucose infusion protocol. The glucose trans port kinetics of Vyska et al (1985) and Feinendegen et al (1986) measured using positron emission to mography (PET) in humans yielded similar llt1/z val ues (1.55 and 1.45 min, respectively). The smallest value of lltlh assumed in the test was 0, which cor responded to infinitely fast blood-brain glucose transport.…”
Section: Brain Glucose Transportmentioning
confidence: 84%
“…The primary effects of glucose trans port on the calculation of V tca are described by the parameter llt1h' Glucose transport kinetic constants of 4.9 mM for Km and 3.6 for V m a x/CMRgl deter mined by l3C NMR (Gruetter et aI., 1992a) with a TCA cycle rate V tca = 0.729 /-lmol min -1 g -1 led to a value of 1.50 min for lltl/2 during a typical [1-l3C]glucose infusion protocol. The glucose trans port kinetics of Vyska et al (1985) and Feinendegen et al (1986) measured using positron emission to mography (PET) in humans yielded similar llt1/z val ues (1.55 and 1.45 min, respectively). The smallest value of lltlh assumed in the test was 0, which cor responded to infinitely fast blood-brain glucose transport.…”
Section: Brain Glucose Transportmentioning
confidence: 84%
“…6-DIG will be of clinical interest only if it can be used to identify variations in glucose transport in vivo, as demonstrated with 3-OMG. In fact, [ 11 C]-3-OMG has been used with dynamic positron emission tomography (PET) to study variations in glucose transport in cardiology [21] and neurology [22,[38][39][40]. However, more recently, Bonadonna et al have used carbon 14-labelled 3-OMG in vivo to identify insulin resistance in the skeletal muscle of patients with type 2 diabetes [1].…”
Section: Discussionmentioning
confidence: 99%
“…D: representative tissue to plasma ratios (TPR) of 11 C-3-OMG radioactivity. [ Figure adapted There have been prior in vivo PET investigations in humans using [ 11 C]3-OMG to study glucose transport across the blood-brain barrier (Vyska et al, 1985;Feinendegen et al, 1986;Brooks et al, 1986aBrooks et al, , 1986b. But the use of this tracer was limited by the fact that it is labelled with carbon 11, a short half-life radioisotope (t 1/2 = 20 minutes) produced by cyclotron, which undoubtedly explains why very few studies have been devoted to this compound.…”
Section: -O-methyl-d-glucose (3-omg)mentioning
confidence: 99%